Razelle Kurzrock, MD
@dr_r_kurzrock
Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
ID: 800362127840022528
20-11-2016 15:36:16
5,5K Tweet
7,7K Takipçi
5,5K Takip Edilen
One of the best parts of being an editor at Clinical Cancer Research is that you have the opportunity to nominate someone to write a commentary or write it yourself. This commentary is about trial outcomes in rare tumors #sarcoma #ehe aacrjournals.org/clincancerres/…
Look who I found at the Rare Disease Symposium in Indianapolis!! Vivek Subbiah, MD Small world for targeted therapy 🌎 🎯🔥
⭐️Exhilarating discussions on how to move to needle in Rare Cancers in the era of personalized medicine & #PrecisionOncology at Indianapolis Rare Disease Symposium Razelle Kurzrock, MD Dr. Ruemu Birhiray, M.D. Dr. Sumeet Bhatia !
ESMO announces the publication of the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S), a new framework to assess the tumour-agnostic potential of #CancerTherapies with the aim to optimise the drug development process Annals of Oncology. 🔗ow.ly/rqmR50T6gHt
💉Durable stable/partial response to atezo-beva in HCC Journal of Clinical Oncology ❗️✅Significant proportion of HCC tumors become ghost tumors (radiologically persistent without viable tumor cells) ➡️Durable: PR/SD >6 mo ➡️IMbrave150 ✔️CR, PR, SD: 8.9%, 22.1%, 44.2% ✔️77.8% of PRs and 28.5%
Ha ha. Whe twitter/X Topol Eric Topol posts our paper before I even knew it was already published Precision Oncology across the Ages Cancer Cell
Razelle Kurzrock, MD at CIMCON2024 to discuss advances in precision oncology over the last decade Mayo Clinic Center for Individualized Medicine Medical College of Wisconsin oncodaily.com/blog/133366 #Cancer #CIMCON2024 #MayoClinicCenter #OncoDaily #Oncology
🤩Thrilled to represent🚂The START Center & be a part of this webinar with Melanoma Research Dana Deighton and🎯TargetCancer Fdn🧬about rare🦓cancers - Looking forward to an engaging discussionRegister and submit your questions now! lnkd.in/eyCcmU-U